Clinical trial
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
NCT06245603 is registered in ClinicalTrials.gov with Istituto Oncologico Veneto IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
- Lead sponsor
- Istituto Oncologico Veneto IRCCS
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 20, 2024
- Completion date
- June 30, 2027
- Enrollment
- 200 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
non-muscle invasive bladder cancer